193 related articles for article (PubMed ID: 18657544)
1. PARP mediates structural alterations in diabetic cardiomyopathy.
Chiu J; Farhangkhoee H; Xu BY; Chen S; George B; Chakrabarti S
J Mol Cell Cardiol; 2008 Sep; 45(3):385-93. PubMed ID: 18657544
[TBL] [Abstract][Full Text] [Related]
2. Oxidative stress-induced, poly(ADP-ribose) polymerase-dependent upregulation of ET-1 expression in chronic diabetic complications.
Chiu J; Xu BY; Chen S; Feng B; Chakrabarti S
Can J Physiol Pharmacol; 2008 Jun; 86(6):365-72. PubMed ID: 18516100
[TBL] [Abstract][Full Text] [Related]
3. PARP activation and the alteration of vasoactive factors and extracellular matrix protein in retina and kidney in diabetes.
Xu B; Chiu J; Feng B; Chen S; Chakrabarti S
Diabetes Metab Res Rev; 2008; 24(5):404-12. PubMed ID: 18351623
[TBL] [Abstract][Full Text] [Related]
4. Poly(ADP-ribose) polymerase 1 inhibition protects cardiomyocytes from inflammation and apoptosis in diabetic cardiomyopathy.
Qin WD; Liu GL; Wang J; Wang H; Zhang JN; Zhang F; Ma Y; Ji XY; Li C; Zhang MX
Oncotarget; 2016 Jun; 7(24):35618-35631. PubMed ID: 27027354
[TBL] [Abstract][Full Text] [Related]
5. Diabetic cystopathy is associated with PARP/JNK/mitochondrial apoptotic pathway-mediated bladder apoptosis.
Li WJ; Oh SJ
Neurourol Urodyn; 2010 Sep; 29(7):1332-7. PubMed ID: 20879002
[TBL] [Abstract][Full Text] [Related]
6. Poly(ADP-ribose) polymerase inhibitors counteract diabetes- and hypoxia-induced retinal vascular endothelial growth factor overexpression.
Obrosova IG; Minchenko AG; Frank RN; Seigel GM; Zsengeller Z; Pacher P; Stevens MJ; Szabó C
Int J Mol Med; 2004 Jul; 14(1):55-64. PubMed ID: 15202016
[TBL] [Abstract][Full Text] [Related]
7. Genotoxic stress and activation of novel DNA repair enzymes in human endothelial cells and in the retinas and kidneys of streptozotocin diabetic rats.
Wang C; George B; Chen S; Feng B; Li X; Chakrabarti S
Diabetes Metab Res Rev; 2012 May; 28(4):329-37. PubMed ID: 22228707
[TBL] [Abstract][Full Text] [Related]
8. PARP-1 inhibition alleviates diabetic cardiac complications in experimental animals.
Zakaria EM; El-Bassossy HM; El-Maraghy NN; Ahmed AF; Ali AA
Eur J Pharmacol; 2016 Nov; 791():444-454. PubMed ID: 27612628
[TBL] [Abstract][Full Text] [Related]
9. Diabetes-induced overexpression of endothelin-1 and endothelin receptors in the rat renal cortex is mediated via poly(ADP-ribose) polymerase activation.
Minchenko AG; Stevens MJ; White L; Abatan OI; Komjáti K; Pacher P; Szabó C; Obrosova IG
FASEB J; 2003 Aug; 17(11):1514-6. PubMed ID: 12824290
[TBL] [Abstract][Full Text] [Related]
10. Poly(ADP-ribose) polymerase inhibition improves erectile function by activation of nitric oxide/cyclic guanosine monophosphate pathway in diabetic rats.
Li WJ; Peng Y; Zhou J; Li B; Wang H; Zhang J; Wang Z
J Sex Med; 2012 May; 9(5):1319-27. PubMed ID: 22429732
[TBL] [Abstract][Full Text] [Related]
11. Role of poly(ADP-ribose) polymerase activation in diabetic neuropathy.
Obrosova IG; Li F; Abatan OI; Forsell MA; Komjáti K; Pacher P; Szabó C; Stevens MJ
Diabetes; 2004 Mar; 53(3):711-20. PubMed ID: 14988256
[TBL] [Abstract][Full Text] [Related]
12. Oxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisited.
Obrosova IG; Drel VR; Pacher P; Ilnytska O; Wang ZQ; Stevens MJ; Yorek MA
Diabetes; 2005 Dec; 54(12):3435-41. PubMed ID: 16306359
[TBL] [Abstract][Full Text] [Related]
13. Poly(ADP-ribose) polymerase-1-deficient mice are protected from angiotensin II-induced cardiac hypertrophy.
Pillai JB; Gupta M; Rajamohan SB; Lang R; Raman J; Gupta MP
Am J Physiol Heart Circ Physiol; 2006 Oct; 291(4):H1545-53. PubMed ID: 16632544
[TBL] [Abstract][Full Text] [Related]
14. PARP-1 inhibition protects the diabetic heart through activation of SIRT1-PGC-1α axis.
Waldman M; Nudelman V; Shainberg A; Abraham NG; Kornwoski R; Aravot D; Arad M; Hochhauser E
Exp Cell Res; 2018 Dec; 373(1-2):112-118. PubMed ID: 30359575
[TBL] [Abstract][Full Text] [Related]
15. PARP inhibition restores erectile function by suppressing corporal smooth muscle apoptosis in diabetic rats.
Li WJ; Zhou J; Li B; Wang H; Peng YB; Wang Z
J Sex Med; 2011 Apr; 8(4):1072-82. PubMed ID: 21235725
[TBL] [Abstract][Full Text] [Related]
16. Poly(ADP-ribose) polymerase inhibition reverses nitrergic neurovascular dysfunctions in penile erectile tissue from streptozotocin-diabetic mice.
Nangle MR; Cotter MA; Cameron NE
J Sex Med; 2010 Oct; 7(10):3396-403. PubMed ID: 20456626
[TBL] [Abstract][Full Text] [Related]
17. Amelioration of diabetes-induced neurobehavioral and neurochemical changes by melatonin and nicotinamide: implication of oxidative stress-PARP pathway.
Jangra A; Datusalia AK; Khandwe S; Sharma SS
Pharmacol Biochem Behav; 2013 Dec; 114-115():43-51. PubMed ID: 24201044
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow expression of poly(ADP-ribose) polymerase underlies diabetic neuropathy via hematopoietic-neuronal cell fusion.
Terashima T; Kojima H; Chan L
FASEB J; 2012 Jan; 26(1):295-308. PubMed ID: 21978940
[TBL] [Abstract][Full Text] [Related]
19. Role of poly(ADP-ribose) polymerase activation in the pathogenesis of periodontitis in diabetes.
Adachi K; Miyajima SI; Nakamura N; Miyabe M; Kobayashi Y; Nishikawa T; Suzuki Y; Kikuchi T; Kobayashi S; Saiki T; Mizutani M; Ohno N; Noguchi T; Mitani A; Matsubara T; Naruse K
J Clin Periodontol; 2017 Oct; 44(10):971-980. PubMed ID: 28570002
[TBL] [Abstract][Full Text] [Related]
20. Poly(ADP-ribose)polymerase inhibition counteracts cataract formation and early retinal changes in streptozotocin-diabetic rats.
Drel VR; Xu W; Zhang J; Kador PF; Ali TK; Shin J; Julius U; Slusher B; El-Remessy AB; Obrosova IG
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1778-90. PubMed ID: 19098320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
